SUMMARY Improved techniques of transvenous pacing have made it possible to use this approach in various congenital cardiac abnormalities. Transvenous active fixation pacing leads were implanted in seven patients aged 15 to 81 years with abnormal venous, atrioventricular, or ventriculoarterial connections with successful ventricular pacing.
For long term pacing the transvenous approach is now widely preferred to the epicardial method because it is more convenient and associated with fewer complications.I The recent availability of a range of active fixation electrodes has resulted in a fall in the displacement rate2 with a wider choice of pacing sites. 3 The stability of this type of endocardial electrode has made it possible to undertake transvenous pacing in adults4 and childrens with cardiac anomalies. We report the use of active fixation electrodes in seven adults (Table) with congenital abnormalities of the heart which would have made conventional pacing methods difficult or impossible.
Case reports CASE 1 A 22 year old man was found to have complete transposition of the great arteries with an associated ventricular septal defect at the age of 7 weeks. He underwent a Blalock procedure at five years of age, Mustard operation and repair of the defect at 13 years, and a revision three years later. After surgery he developed atrial tachycardias and atrioventricular block. An epicardial pacemaker was implanted. This system failed because of exit block, and an endocardial approach was attempted. A Helifix (Vitatron) lead was introduced via the right subclavian vein, manipulated past the interatrial baffle, and positioned in the posterior morphologically left (venous) ventricle (Fig. 1) . During follow up for 10 months there has been stable pacing. Endocardial pacing in congenital heart disease This patient was noted to be cyanosed at 1 month of age. Catheterisation showed complete transposition with infundibular pulmonary stenosis, a ventricular septal defect, and a patent foramen ovale. At the age of 13 years a Rastelli procedure was performed after which he developed complete atrioventricular block. An epicardial pacing system was implanted but eroded through the skin after one year and was revised. In 1981 an endocardial system was inserted. A Medtronic 6959 screw in electrode was inserted via the left cephalic vein and positioned in the right ventricle. Care was taken to obtain satisfactory endocardial electrocardiograms before advancing the screw, thus ensuring that the prosthetic material used in the repair was avoided. The system was revised because of exit block a year later. A similar approach was used and proved to be entirely successful. analgesics. The output of the unit was reprogrpnmed from 5 0 to 2-5 volts and diaphragmatic stimulation ceased. Unfortunately, diaphragmatic stimulation returned after several weeks and resiting of the electrode was undertaken three and a half months after the initial implant. She has now been followed for two months without further problems. A satisfactory endocardial pacing threshold was obtained in all patients (Table) . In the five patients in whom an endocardial R wave potential was obtained, this was satisfactory in all. Multiprogrammable pacemakers were used in each case to provide greater flexibility during surveillance.
Comment
The indication for permanent pacing in our patients was complete atrioventricular block in six (in three this rhythm was a complication of a surgical procedure) and sinuatrial disease in one. In four patients epicardial systems had been used previously, and in each these systems had caused problems. For this reason, or because of previous cardiac surgery, we decided to attempt transvenous pacing electively using active fixation electrodes. There is little doubt that the incidence of dislocation of endocardial leads has been considerably reduced by the use of these Endocardial pacing in congenital heart disease electrodes.2 In addition, long term pacing at unconventional sites is possible with certain types of active fixation electrode. 3 In children large loops may be fashioned to allow for growth.S This could cause instability of passive fixation (tined) or non-fixation leads. These findings coupled with improved venous access6 led us to believe that long term endocardial pacing could be achieved in selected patients with congenital abnormalities of venous, atrioventricular, and ventriculoarterial connections.
The advantages of active fixation electrodes for endocardial pacing via a persistent left superior vena cava have been emphasised previously. 4 In both patients with this anomaly reported here epicardial pacing systems had been unsuccessful. In the five other patients endocardial pacing was possible despite abnormal atrioventricular or ventriculoarterial connections. In the patient with a Rastelli repair an active fixation lead was chosen to allow greater choice of endocardial sites in the presence of a considerable amount of prosthetic material. The electrode was sited in the morphologically left ventricle in four of our patients. It is likely that conventional electrodes would be unsuitable for long term pacing in this relatively smooth walled chamber because of poor stability. In three of these patients the left ventricle was the venous ventricle but in one (case 2) it gave rise to the aorta. There is, therefore, a small risk of systemic emboli in this patient but there has been no clinical evidence of this. Where appropriate, however, long term anticoagulant treatment is a reasonable precaution. In two patients (cases 4 and, 7) in whom the pacing electrode was inserted into a morphologically left ventricle diaphragmatic stimulation occurred which ceased when the output of the pacemaker was reduced. It seems likely that in this situation penetration of the myocardium may occur because the ventricle is smooth and thin walled without trabeculation. If this is recognised at operation resiting the electrode to another area should avoid this problem.
The advantages of endocardial pacing over epicardial pacing in the presence of congenital cardiac abnormalities which have required previous surgery have been emphasised by McGoon et al. 7 They described four patients with complex congenital heart disease in whom atrial pacing was undertaken to control sinus bradycardia and atrial arrhythmiias. This approach would have been inappropriate in six of our 329 patients, however, because the cause of the bradycardia was atrioventricular block.
In conclusion, transvenous endocardial pacing in adult patients with congenital cardiac abnormalities is made possible by recent advances in permanent electrode design and improved methods of implantation. Even in the presence of complex lesions it may be possible to locate the electrode at a stable endocardial site. Transvenous pacing is preferrable to epicardial pacing because thoracotomy is avoided. This consideration is especially important in patients who have had one or several previous cardiac operations which may make further surgery technically difficult. In patients with complex anomalies, angiographic or echocardiographic delineation of the anatomical defects is essential before permanent endocardial pacing, whether atrial or ventricular, is attempted.
